谭海宁山东大学主页平台管理系统--中文主页

更多

` 中文
- English

谭海宁

职称：教授
所在单位：国家糖工程技术研究中心

教师拼音名称：tanhaining
入职时间：2009-07-16
所在单位：国家糖工程技术研究中心
性别：男
在职信息：在职
是否在职：1

论文成果

[16] 李妍. CD44 targeting nanodrug based on chondroitin sulfate for melanoma therapy by inducing mitochondrial apoptosis pathways. Carbohydrate Polymers, 2023.
[17] 唐雯. Review: Application of chitosan and its derivatives in medical materials. International Journal of Biological Macromolecules, 2023.
[18] . Glycol-split heparin-linked prodrug nanoparticles target the mitochondrion apparatus for cancer metastasis treatment. small, 2023.
[19] 张惠. Research on the secondary structure and hydration water around human serum albumin induced by ethanol with infrared and near-infrared spectroscopy. JOURNAL OF MOLECULAR STRUCTURE Journal, 2023.
[20] 张惠. Improved Principal Component Analysis (IPCA): A Novel Method for Quantitative Calibration Transfer between Different Near-Infrared Spectrometers. Molecules, 406, 2023.
[21] Gong, Zhongying. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy. ACS. Appl. Mater. Interfaces, 13, 55913, 2021.
[22] 李妍. Dezhou donkey (Equus asinus) milk a potential treatment strategy for type 2 diabetes. 《Journal ofEthnopharmacology》, 246, 2020.
[23] 谭海宁. A Review of Bioactive Peptides: Chemical Modification, Structural Characterization and Therapeutic Applications. Journal of Biomedical Nanotechnology, 2021.
[24] 侯慧文. A Review of Bioactive Peptides: Chemical Modification, Structural Characterization and Therapeutic Applications. Journal of Biomedical Nanotechnology, 16, 1687, 2020.
[25] 刘元秀. Progress in the polymer-paclitaxel conjugate. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 54, 2019.
[26] 李妍. Dezhou donkey (Equus asinus) milk a potential treatment strategy for type 2 diabetes. 《Journal ofEthnopharmacology》, 2020.
[27] 翟光喜. Preparation of chitosan-based nanoparticles for delivery of low molecular weight heparin.. J Biomed Nanotech, 7, 696, 2011.
[28] 谭海宁 and 王凤山. Improved stability and enhanced anti-tumor activity of hyaluronic acid modified ES2-AF nanoparticle-like conjugate. Journal of Biomedical Nanotechnology, 2019.
[29] 谭海宁. Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018.
[30] 王凤山 , 谭海宁 and 孙凤. Hyaluronic acid-endostatin2-alft1 (HA-ES2-AF) nanoparticle-like conjugate for the target treatment of diseases. Journal of Controlled Release, 288, 1, 2018.

共72条 2/5

首页上页下页尾页页

扫一扫用手机查看